153 related articles for article (PubMed ID: 31186748)
21. Protecting Ovaries During Chemotherapy Through Gonad Suppression: A Systematic Review and Meta-analysis.
Elgindy E; Sibai H; Abdelghani A; Mostafa M
Obstet Gynecol; 2015 Jul; 126(1):187-95. PubMed ID: 26241272
[TBL] [Abstract][Full Text] [Related]
22. Depot versus daily administration of gonadotrophin releasing hormone agonist protocols for pituitary desensitization in assisted reproduction cycles.
Albuquerque LE; Saconato H; Maciel MC
Cochrane Database Syst Rev; 2005 Jan; (1):CD002808. PubMed ID: 15674898
[TBL] [Abstract][Full Text] [Related]
23. GnRHa for Ovarian Protection and the Association between AMH and Ovarian Function during Adjuvant Chemotherapy for Breast Cancer.
Zhong Y; Lin Y; Cheng X; Huang X; Zhou Y; Mao F; Wang Y; Guan J; Shen S; Xu Y; Peng L; Li Y; Cao X; Sun Q
J Cancer; 2019; 10(18):4278-4285. PubMed ID: 31413747
[No Abstract] [Full Text] [Related]
24. Gonadotrophin-releasing hormone agonist protocols for pituitary suppression in assisted reproduction.
Maheshwari A; Gibreel A; Siristatidis CS; Bhattacharya S
Cochrane Database Syst Rev; 2011 Aug; (8):CD006919. PubMed ID: 21833958
[TBL] [Abstract][Full Text] [Related]
25. WITHDRAWN: Gonadotrophin-releasing hormone agonist protocols for pituitary desensitization in in vitro fertilization and gamete intrafallopian transfer cycles.
Daya S
Cochrane Database Syst Rev; 2007 Jul; (1):CD001299. PubMed ID: 17636664
[TBL] [Abstract][Full Text] [Related]
26. Protection of ovarian function by GnRH agonists during chemotherapy: a meta-analysis.
Sun X; Dongol S; Jiang J; Kong B
Int J Oncol; 2014 Apr; 44(4):1335-40. PubMed ID: 24535045
[TBL] [Abstract][Full Text] [Related]
27. Depot versus daily administration of gonadotrophin releasing hormone agonist protocols for pituitary desensitization in assisted reproduction cycles.
Albuquerque LE; Saconato H; Maciel MC
Cochrane Database Syst Rev; 2002; (3):CD002808. PubMed ID: 12137658
[TBL] [Abstract][Full Text] [Related]
28. GnRH agonist leuprolide acetate does not confer any protection against ovarian damage induced by chemotherapy and radiation in vitro.
Bildik G; Akin N; Senbabaoglu F; Sahin GN; Karahuseyinoglu S; Ince U; Taskiran C; Selek U; Yakin K; Guzel Y; Ayhan C; Alper E; Cetiner M; Balaban B; Mandel NM; Esen T; Iwase A; Urman B; Oktem O
Hum Reprod; 2015 Dec; 30(12):2912-25. PubMed ID: 26466909
[TBL] [Abstract][Full Text] [Related]
29. Prevention of irreversible chemotherapy-induced ovarian damage in young women with lymphoma by a gonadotrophin-releasing hormone agonist in parallel to chemotherapy.
Blumenfeld Z; Avivi I; Linn S; Epelbaum R; Ben-Shahar M; Haim N
Hum Reprod; 1996 Aug; 11(8):1620-6. PubMed ID: 8921104
[TBL] [Abstract][Full Text] [Related]
30. Effects of GnRHa on early embryonic development in mice receiving cyclophosphamide.
Kanter M; Sapmaz-Metin M; Serez B
Arch Gynecol Obstet; 2016 Jan; 293(1):203-209. PubMed ID: 26246413
[TBL] [Abstract][Full Text] [Related]
31. Utility of gonadotropin-releasing hormone agonists for prevention of chemotherapy-induced ovarian damage in premenopausal women with breast cancer: a systematic review and meta-analysis.
Shen YW; Zhang XM; Lv M; Chen L; Qin TJ; Wang F; Yang J; Liu PJ; Yang J
Onco Targets Ther; 2015; 8():3349-59. PubMed ID: 26622183
[TBL] [Abstract][Full Text] [Related]
32. [Influence of gonadotropin-releasing hormone agonist on the effects of chemotherapy upon ovarian cancer: an experimental study with rat model].
Yuan GW; Shen K; Yang JX
Zhonghua Yi Xue Za Zhi; 2005 Jun; 85(20):1428-31. PubMed ID: 16029659
[TBL] [Abstract][Full Text] [Related]
33. Administration effects of single-dose GnRH agonist for luteal support in females undertaking IVF/ICSI cycles: A meta-analysis of randomized controlled trials.
Song M; Liu C; Hu R; Wang F; Huo Z
Exp Ther Med; 2020 Jan; 19(1):786-796. PubMed ID: 31885714
[TBL] [Abstract][Full Text] [Related]
34. Pharmacological interventions for fertility preservation during chemotherapy: a systematic review and meta-analysis.
Ben-Aharon I; Gafter-Gvili A; Leibovici L; Stemmer SM
Breast Cancer Res Treat; 2010 Aug; 122(3):803-11. PubMed ID: 20571868
[TBL] [Abstract][Full Text] [Related]
35. Ovarian suppression using luteinizing hormone-releasing hormone agonists during chemotherapy to preserve ovarian function and fertility of breast cancer patients: a meta-analysis of randomized studies.
Lambertini M; Ceppi M; Poggio F; Peccatori FA; Azim HA; Ugolini D; Pronzato P; Loibl S; Moore HC; Partridge AH; Bruzzi P; Del Mastro L
Ann Oncol; 2015 Dec; 26(12):2408-19. PubMed ID: 26347105
[TBL] [Abstract][Full Text] [Related]
36. Effect of Gonadotrophin-Releasing Hormone Agonist Addition for Luteal Support on Pregnancy Outcome in vitro Fertilization/Intracytoplasmic Sperm Injection Cycles: A Meta-Analysis Based on Randomized Controlled Trials.
Ma X; Du W; Hu J; Yang Y; Zhang X
Gynecol Obstet Invest; 2020; 85(1):13-25. PubMed ID: 31422404
[TBL] [Abstract][Full Text] [Related]
37. Effect of Timing of Gonadotropin-Releasing Hormone Agonist Administration for Ovarian Protection in Patients with Breast Cancer.
Shin JJ; Choi YM; Jun JK; Lee KH; Kim TY; Han W; Im SA
J Breast Cancer; 2020 Jun; 23(3):268-278. PubMed ID: 32595989
[TBL] [Abstract][Full Text] [Related]
38. Perspectives on the co-treatment with GnRHa in female patients undergoing hematopoietic stem cell transplantation.
Cima LN; Colita A; Fica S
Endocr Connect; 2017 Nov; 6(8):R162-R170. PubMed ID: 28947558
[TBL] [Abstract][Full Text] [Related]
39. Potential Mechanisms of Ovarian Protection with Gonadotropin-Releasing Hormone Agonist in Breast Cancer Patients: A Review.
Poggio F; Lambertini M; Bighin C; Conte B; Blondeaux E; D'Alonzo A; Dellepiane C; Buzzatti G; Molinelli C; Boccardo F; Del Mastro L
Clin Med Insights Reprod Health; 2019; 13():1179558119864584. PubMed ID: 31391786
[TBL] [Abstract][Full Text] [Related]
40. Bilateral Salpingo-oophorectomy Compared to Gonadotropin-Releasing Hormone Agonists in Premenopausal Hormone Receptor-Positive Metastatic Breast Cancer Patients Treated with Aromatase Inhibitors.
Suh KJ; Kim SH; Lee KH; Kim TY; Kim YJ; Han SW; Kang E; Kim EK; Kim K; No JH; Han W; Noh DY; Lee M; Kim HS; Im SA; Kim JH
Cancer Res Treat; 2017 Oct; 49(4):1153-1163. PubMed ID: 28253566
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
